Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution Channel - Forecast 2024-2030
19 mars 2024 17h49 HE
|
Research and Markets
Dublin, March 19, 2024 (GLOBE NEWSWIRE) -- The "Global Anterior Uveitis Treatment Market by Treatment Type (Anti-Tumor Necrosis Factor Agents, Corticosteroids, Cycloplegic Agents), Distribution...
Global Ophthalmic Eye Droppers Market Report 2024: A $25.88 Billion Opportunity by 2034 with Regional and Country-Level Data for Types, Drugs, Treatments, and End-users
12 mars 2024 12h13 HE
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmic Eye Dropper Market by Type, by Drug Type, by Treatment Type, by End-user, and By Region" report has been added to ...
OCS-02 (Licaminlimab) for Autoimmune Uveitis for 7MM: Market Size, Forecasts, and Emerging Insights, 2019-2023 and 2024-2032
04 mars 2024 11h35 HE
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "OCS-02 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.The report provides...
Dry Age-related Macular Degeneration (Dry-AMD) Drug Pipeline Insight Landscape Report 2024: Comprehensive Insights About 70+ Companies and 80+ Pipeline Drugs
01 mars 2024 08h54 HE
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Dry Age-related Macular Degeneration (Dry-AMD) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This...
US YUTIQ Autoimmune Uveitis Market Evaluation Now Available: Comprehensive Insight and Forecast up to 2032
29 févr. 2024 10h50 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "US YUTIQ Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering The expansive analysis...
Myopia Pipeline Insights Report 2024: Latest Progress in Nearsightedness Therapeutics
27 févr. 2024 11h20 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Myopia - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The healthcare sector has observed a surge in research...
Retinitis Pigmentosa Pipeline Insight Report 2024: Unveiling New Horizons in Genetic Disorder Therapeutics
27 févr. 2024 11h12 HE
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Retinitis Pigmentosa - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The global medical community is set to...
Thyroid Eye Disease Treatment Market Poised for Significant Growth as Demands Surge, States New 2023-2029 Global Industry Forecast
20 févr. 2024 04h58 HE
|
Research and Markets
Dublin, Feb. 20, 2024 (GLOBE NEWSWIRE) -- The "Global Thyroid Eye Disease (TED) Treatment Market (2023 Edition): Analysis By Therapeutic Type, Route of Administration, Distribution Channel, By...
DEXTENZA Drug Insight and U.S. Market Forecast to 2032: Navigating Clinical Trials, Regulatory Milestones, and Market Growth Potential in the Treatment of Acute Ocular Pain
30 janv. 2024 10h48 HE
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "United States DEXTENZA Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report provides an...
INVELTYS (loteprednol etabonate/KPI-121) Drug Insight and U.S. Market Analysis, 2023-2032: Projected to Dominate the Acute Ocular Pain (AOP) Sector
29 janv. 2024 12h51 HE
|
Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "United States INVELTYS Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. This report offers an...